Comparative next-generation sequencing of adeno-associated virus inverted terminal repeats

BioTechniques

Volumn 56, Issue 5, 2014, Pages 269-273

  Petri, Karl ^a   Fronza, Raffaele ^a   Gabriel, Richard ^a   Käppel, Christine ^a   Nowrouzi, Ali ^a   Linden, R Michael ^b   Henckaerts, Els ^b   Schmidt, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adeno associated virus; Inverted terminal repeat; Next generation sequencing

Indexed keywords

RECOMBINANT DNA;

ADENO ASSOCIATED VIRUS; AMPLICON; ARTICLE; BIOINFORMATICS; COMPARATIVE STUDY; CONSENSUS SEQUENCE; DNA BASE COMPOSITION; DNA SEQUENCE; GENE INSERTION SEQUENCE; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; INVERTED TERMINAL REPEAT; POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; SEQUENCE ANALYSIS; DEPENDOPARVOVIRUS; GENETICS; HELA CELL LINE; LONG TERMINAL REPEAT; MUTATION; PROCEDURES; VIROLOGY;

DEPENDOVIRUS; HELA CELLS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TERMINAL REPEAT SEQUENCES;

EID: 84900461488     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/000114170     Document Type: Article

References (22)

1. Mingozzi, F. and K.A. High. 2011. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 12:341-355.
2. Kaeppel, C., S.G. Beattie, R. Fronza, R. van Logtenstein, F. Salmon, S. Schmidt, S. Wolf, A. Nowrouzi, et al. 2013. A largely random AAV integration profile after LPLD gene therapy. Nat. Med. 19:889-891.
3. Gaudet, D., J. Methot, S. Dery, D. Brisson, C. Essiembre, G. Tremblay, K. Tremblay, J. de Wal, et al. 2013. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther. 20:361-369.
4. Maguire, A.M., F. Simonelli, E.A. Pierce, E.N. Pugh, Jr., F. Mingozzi, J. Bennicelli, S. Banfi, K.A. Marshall, et al. 2008. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358:2240-2248.
5. Bainbridge, J.W., A.J. Smith, S.S. Barker, S. Robbie, R. Henderson, K. Balaggan, A. Viswanathan, G.E. Holder, et al. 2008. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358:2231-2239.
6. Flotte, T.R., B.C. Trapnell, M. Humphries, B. Carey, R. Calcedo, F. Rouhani, M. Campbell-Thompson, A.T. Yachnis, et al. 2011. Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: interim results. Hum. Gene Ther. 22:1239-1247.
7. Nathwani, A.C., E.G. Tuddenham, S. Rangarajan, C. Rosales, J. McIntosh, D.C. Linch, P. Chowdary, A. Riddell, et al. 2011. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365:2357-2365.
8. Jessup, M., B. Greenberg, D. Mancini, T. Cappola, D.F. Pauly, B. Jaski, A. Yaroshinsky, K.M. Zsebo, et al. 2011. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124:304-313.
9. Donsante, A., D.G. Miller, Y. Li, C. Vogler, E.M. Brunt, D.W. Russell, and M.S. Sands. 2007. AAV vector integration sites in mouse hepatocellular carcinoma. Science 317:477.
10. Rosas, L.E., J.L. Grieves, K. Zaraspe, K.M. La Perle, H. Fu, and D.M. McCarty. 2012. Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity. Mol Ther. 20:2098-2110.
11. Henckaerts, E. and R.M. Linden. 2010. Adeno-associated virus: a key to the human genome? Future Virol. 5:555-574.
12. Wang, X.S., S. Ponnazhagan, and A. Srivastava. 1996. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions. J. Virol. 70:1668-1677.
13. Srivastava, A., E.W. Lusby, and K.I. Berns. 1983. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45:555-564.
14. Duan, D., Z. Yan, Y. Yue, and J.F. Engelhardt. 1999. Structural analysis of adeno-associated virus transduction circular intermediates. Virology 261:8-14.
15. Mroske, C., H. Rivera, T. Ul-Hasan, S. Chatterjee, and K.K. Wong. 2012. A capillary electrophoresis sequencing method for the identification of mutations in the inverted terminal repeats of adeno-associated virus. Human gene therapy. Part B. Hum Gene Ther Methods. 23:128-136.
16. Hüser, D., A. Gogol-Doring, T. Lutter, S. Weger, K. Winter, E.M. Hammer, T. Cathomen, K. Reinert, and R. Heilbronn. 2010. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome. PLoS Pathog. 6:e1000985.
17. Li, H., N. Malani, S.R. Hamilton, A. Schlachterman, G. Bussadori, S.E. Edmonson, R. Shah, V.R. Arruda, et al. 2011. Assessing the potential for AAV vector genotoxicity in a murine model. Blood 117:3311-3319.
18. Wang, Z., L. Lisowski, M.J. Finegold, H. Nakai, M.A. Kay, and M. Grompe. 2012. AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence. Mol Ther. 20:1902-1911.
19. Nowrouzi, A., M. Penaud-Budloo, C. Kaeppel, U. Appelt, C. Le Guiner, P. Moullier, C. von Kalle, R.O. Snyder, and M. Schmidt. 2012. Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver. Mol Ther. 20:1177-1186.
20. Schmidt, M., K. Schwarzwaelder, C. Bartholomae, K. Zaoui, C. Ball, I. Pilz, S. Braun, H. Glimm, and C. von Kalle. 2007. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat. Methods 4:1051-1057.
21. Robinson, J.T., H. Thorvaldsdottir, W. Winckler, M. Guttman, E.S. Lander, G. Getz, and J.P. Mesirov. 2011. Integrative genomics viewer. Nat. Biotechnol. 29:24-26.
22. Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, et al. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079.